Patriot Transportation (NASDAQ:PATI) reported quarterly earnings of $0.13 per share. This is a 1200 percent increase over earnings of $0.01 per share from the same period last year.
Vincerx Pharma Announced Clinical Efficacy Of Enitociclib In Combination With Venetoclax And Prednisone In Lymphoma; Investigators From The NIH Report 2 Partial Responses In 3 Peripheral T-cell Lymphoma Patients And 1 PR In 2 Double-hit Diffuse Large…
Vincerx Pharma, Inc. (NASDAQ:VINC) (“Vincerx”), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced